# Maimonides Minocycline in Stroke Study

> **NCT06107725** · PHASE2,PHASE3 · TERMINATED · sponsor: **Maimonides Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Stroke, Acute
- Ischemic Stroke
- Hemorrhagic Stroke
- Mortality
- Morbidity

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT06107725
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-11-01
- **Primary completion:** 2024-05-09
- **Final completion:** 2024-05-09
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The protocol is in the process to change due to challenges in recruiting participants (without a treatment arm) which is now reflected in 2024-04-01
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107725, "Maimonides Minocycline in Stroke Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06107725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*